Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

被引：0
|
作者：
Gaia, S [1 ]
Marzano, A [1 ]
Ciardo, V [1 ]
Gentilcore, E [1 ]
Lagget, M [1 ]
Smedile, A [1 ]
Rizzetto, M [1 ]
机构：
[1] Molinette Mauriziano Hosp, Dept Gastroenterol, Turin, Italy
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80111-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
112
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation
    Rosenau, Jens
    Hooman, Nazanin
    Hadem, Johannes
    Rifai, Kinan
    Bahr, Matthias J.
    Philipp, Gunnar
    Tillmann, Hans L.
    Klempnauer, Juergen
    Strassburg, Christian P.
    Manns, Michael P.
    LIVER TRANSPLANTATION, 2007, 13 (03) : 367 - 373
  • [22] Intramuscular hepatitis B immune globulin combined with oral lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
    Yao, F
    Osorio, R
    Roberts, J
    Poordad, F
    Steady, S
    Gish, R
    HEPATOLOGY, 1998, 28 (04) : 260A - 260A
  • [23] Five year follow-up of a randomized study comparing lamivudine vs. lamivudine plus HBIg in the prevention of hbv recurrence after liver transplantation
    Buti, M
    Prieto, M
    Casafont, F
    Gonzalez, A
    Miras, M
    Herrero, JI
    Jardi, R
    Hebron, V
    Esteban, R
    HEPATOLOGY, 2005, 42 (04) : 491A - 492A
  • [24] Intramuscular hepatitis B immune globuline (IM HBIG) combined lamivudine is effective prophylaxis against hepatitis B recurrence irrespective of replicative HBV status.
    Kim, DG
    Choi, JY
    Kim, SJ
    Moon, IS
    Lee, MD
    LIVER TRANSPLANTATION, 2006, 12 (05) : C68 - C68
  • [25] Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation
    Sousa, JM
    Pareja, F
    Serrano, J
    Gómez, MA
    García, I
    Tamayo, MJ
    Díaz, C
    Martín, C
    Pascasio, JM
    Hinojosa, R
    Pérez-Bernal, JB
    Cañas, E
    Sayago, M
    Bernardos, A
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 723 - 724
  • [26] Prolonged follow-up of HBV liver transplanted patients: Results from a randomized study comparing lamivudine vs. lamivudine plus HBIg in the prevention of HBV recurrence after liver transplantation
    Buti, M
    Mas, A
    Prieto, M
    Casafont, F
    Gonzalez, A
    Miras, M
    Valdes, A
    Herrero, J
    JOURNAL OF HEPATOLOGY, 2003, 38 : 37 - 37
  • [27] Occurrence of YMDD mutation prior to liver transplantation (OLT) enhances the risk of early recurrence of hepatitis B after transplantation in spite of combination reinfection prophylaxis with lamivudine and hepatitis B immune globulin (HBIG).
    Rosenau, J
    Bahr, MJ
    Tillmann, HL
    Jaeckel, R
    Trautwein, C
    Klempnauer, J
    Manns, MP
    Boker, KH
    HEPATOLOGY, 2000, 32 (04) : 293A - 293A
  • [28] Long-term outcomes of preventing HBV recurrence with nucleotide and HBIG after liver transplantation for hepatitis B associated liver disease
    Chang, S. H.
    TRANSPLANTATION, 2021, 105 (08) : 93 - 93
  • [29] Combined therapy with low dose hepatitis B immunoglobulin (HBIG) and lamivudine (LAM) in patients transplanted for HBV chronic liver disease: Long term efficacy and costs
    Giusto, M.
    Gentili, F.
    Loria, I.
    Grieco, S.
    Rossi, M.
    Novelli, G.
    Berloco, P.
    Ferretti, G.
    Corradini, S. Ginanni
    Attili, A. F.
    Merli, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S84 - S84
  • [30] Intramuscular hepatitis B immune globulin and lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
    Choi, J
    Bae, S
    Yoon, S
    Han, JY
    Yang, J
    Lee, Y
    Cha, S
    Chung, K
    Sun, H
    Park, D
    HEPATOLOGY, 2002, 36 (04) : 184A - 184A
12345